July VOICE is here!

Surprise! The July issue of the CHR VOICE is here. We thought we’d have the summer off but a few burning issues came up, including the experimental AUGMENT<sup>SM</sup> treatment. Also, Dr. Gleicher explores medical complications during pregnancy, Dr. Albertinti takes us to the microscopic surface of the ovary, and we celebrate a new patent for CHR’s novel use of DHEA.

Norbert Gleicher, MD, leads CHR’s clinical and research efforts as Medical Director and Chief Scientist. A world-renowned reproductive endocrinologist, Dr. Gleicher has published hundreds of peer-reviewed papers and lectured globally while keeping an active clinical career focused on ovarian aging, immunological issues and other difficult cases of infertility.